Human Clinical Study!
Next generation dual action carb blocker!
Reduces glycemic index of foods!
InSea²™ is the only product on the market today that exhibits a dual mechanism of action against the two digestive enzymes involved in the digestion and assimilation of carbohydrates ingested during a meal (amylase and sucrase). From natural origin, InSea²™ is an optimized blend of polyphenols derived from two species of brown seaweeds. In clinical study, InSea²™ significantly decreased blood glucose and insulin responses that follow a high carbohydrate meal, and improved insulin sensitivity. InSea²™ may thus be used in formulations of natural health products aiming at reducing the glycemic index of foods.
Results from this clinical trial were recently presented at the international Experimental Biology meeting and were submitted for publication in a peer-reviewed medical journal.
InSea2™ is offered from our partners in the following territories:
United States of America:
55 62 3316.3530
PT Demka Sakti
Berli Jucker Public Company Ltd.